In addition to tumor-infiltrating T cells, many EOC patients mount serum autoantibody responses to a variety of tumor antigens, including NY-ESO-1, HOXA7, Ep-CAM, HSP-90, MUC-1 and p53 [23]–[25]. Here, MUC1 is linked to neoplasm.